"1er Sanatorio Polivalente del Norte Argentino, acreditado por ITAES (Instituto Técnico para la Acreditación de Establecimientos de Salud)"

During the past decade, Clinica Mayo de UMCB conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 6 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 6 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinica Mayo de UMCB" #1 sponsor was "Janssen Research & Development, LLC" with 7 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Pfizer" with 2 trials sponsored, "Corvus Pharmaceuticals, Inc." with 1 trials sponsored and "Horizon Therapeutics Ireland DAC" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Clinica Mayo de UMCB" are "Respiratory Syncytial Virus Infections" (3 trials), "Depressive Disorder, Major" (2 trials), "Type 2 Diabetes Mellitus" (2 trials), "Covid-19" (1 trials) and "Diabetes" (1 trials). Many other conditions were trialed in "Clinica Mayo de UMCB" in a lesser frequency.

Most popular intervention types in "Clinica Mayo de UMCB" are "Drug" (14 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Insulin Degludec" (2 trials), "RSVpreF" (2 trials), "Rilematovir" (2 trials) and "Seltorexant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinica Mayo de UMCB" are 14 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Clinica Mayo de UMCB". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Clinica Mayo de UMCB, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Clinica Mayo de UMCB, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".